DMAC Operating Cash Flow (Statement)

Diamedica Therapeutics Inc · Operating Cash Flow (Statement)

DMAC logo

DMAC Operating Cash Flow (Statement)

Latest reported-$8.11M
DMAC Quarterly Cash from Operations (-$226.17K → -$8.11M)
High-resolution chart · PNG

DMAC operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Diamedica Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-8,114,000
-9,082,000
-7,765,000
-6,604,860
-7,598,000
-7,149,000
-6,434,000
-4,470,000
-4,519,000
-6,653,000
-3,812,000
-4,797,000
-5,030,000
-5,089,000
-2,766,000
-2,361,000
-2,496,000
-3,888,000
-2,804,000
-3,046,000
-2,089,000
-4,313,000
-3,016,000
-2,347,000
-844,000
-2,978,000
-1,865,000
-1,232,000
-2,871,000
-3,134,000
-1,910,886
-1,856,729
-1,024,146
-904,239
-974,825
-679,023
-1,422,946
-823,206
-1,278,612
-924,460
-401,118
-418,990
-345,638
-98,633
-582,447
-339,213
-124,186
-567,408
-1,924,070
-1,140,012
-449,017
-1,121,781
-2,064,331
-1,867,478
-1,443,959
-1,955,802
-1,400,287
-683,777
-1,251,847
-811,507
-713,363
-659,300
-528,116
392,765
-1,938,387
-303,031
-482,341
-574,002
-626,657
-463,707
-96,684
-741,275
-631,810
3,413
-193,137
-704,019
-168,334
-147,861
-226,165
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.